Francis Wright, M.D. appointed as Chair of Chronic Kidney Disease Task Force

Translate to Spanish or other 102 languages!

Governor Greg Abbott named Francis Wright, M.D. as Chair of the Chronic Kidney Disease Task Force for a term at the pleasure of the Governor. Image source:  texaskidney.org
Governor Greg Abbott named Francis Wright, M.D. as Chair of the Chronic Kidney Disease Task Force for a term at the pleasure of the Governor. Image source:  texaskidney.org

Mega Doctor News

- Advertisement -

AUSTIN, Texas – Governor Greg Abbott named Francis Wright, M.D. as Chair of the Chronic Kidney Disease Task Force for a term at the pleasure of the Governor. The task force coordinates implementation of the state’s plan for prevention, early screening, diagnosis, and management of chronic kidney disease and educates health care professionals.

Francis Wright, M.D. of San Antonio is the Medical Director for Transplant Care Consultants and previously served as Surgical Director and Transplant Surgeon at the Methodist Specialty and Transplant Hospital in San Antonio since 1994. He did an organ transplant fellowship at the University of Iowa Hospitals in 1988 where he was on the surgery faculty. He was the founding director of the kidney and pancreas transplant programs at Centennial Medical Center in Nashville prior to returning to San Antonio. He is certified by the American Board of Surgery and is a Fellow of the American College of Surgeons. He is a member of the American Society of Transplant Surgeons, Texas Transplant Society, American Transplantation Society, and the International Transplantation Society. He has served on boards and committees for the State of Texas Kidney Foundation, the American Foundation for Donation and Transplantation, the US Renal Network 14, and the United Network for Organ Sharing. Wright received a Doctor of Medicine degree from The University of Texas Health Science Center at San Antonio.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.

DHR Health Expands Ophthalmology Services with Addition of Dr. Rachel Gelman

 Continuing its mission to provide exceptional medical care to patients across the Rio Grande Valley, DHR Health is pleased to welcome ophthalmologist Dr. Rachel Gelman to its team of healthcare providers.

STHS McAllen Welcomes Aspiring Youth for an Interactive Look Inside Healthcare

As the demand for healthcare professionals continues to grow, introducing young students to the wide range of opportunities available in the medical field is more important than ever. From nurses and physicians to emergency responders, pharmacists and other essential healthcare workers, each plays a critical role in caring for patients and keeping communities healthy.
- Advertisement -